Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
Lampros Chrysavgis, Eleftheria Ztriva, Άδωνις Πρωτοπαπάς, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 42, pp. 6514-6528
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
Soo Lim, Jin–Wook Kim, Giovanni Targher
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 7, pp. 500-514
Closed Access | Times Cited: 147
Non-alcoholic fatty liver disease: Definition and subtypes
Seulki Han, Soon Koo Baik, Moon Young Kim
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S5-S16
Open Access | Times Cited: 102
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment
Ankoor Patel, Dhiraj Peddu, Sahil Amin, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 22
Endonuclease G promotes hepatic mitochondrial respiration by selectively increasing mitochondrial tRNA Thr production
Xihui Xu, Rozhin Penjweini, Lóránt Székvölgyi, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 1
Open Access
Comparative application of MAFLD and MASLD diagnostic criteria on NAFLD patients: insights from a single-center cohort
Maha Elsabaawy, Madiha Naguib, Ahmed Abuamer, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Metabolic dysfunction associated steatotic liver disease in lean patients. Diagnostic and treatment challenges
E. E. Zabotina, Yu. A. Khabarova, N. Yu. Stukova
Experimental and Clinical Gastroenterology (2025), Iss. 9, pp. 96-109
Closed Access
Non-alcoholic Fatty Liver Disease, Metabolic syndrome, and Type 2 diabetes mellitus: Where do we stand today?
Bojan Mitrovic, Milan Obradović, Zoran Gluvić, et al.
Archives of Medical Science (2022)
Open Access | Times Cited: 21
From NAFLD to MASLD: When metabolic comorbidity matters
Shan Hong, Lei Sun, Yiwei Hao, et al.
Annals of Hepatology (2023) Vol. 29, Iss. 2, pp. 101281-101281
Open Access | Times Cited: 11
Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of Obesity
Ioannis I. Moustakas, Angeliki Katsarou, Aigli‐Ioanna Legaki, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3446-3446
Open Access | Times Cited: 24
Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease
Jarren R. Oates, Keisuke Sawada, Daniel A. Giles, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
Ιωάννα Αγγελετοπούλου, Maria Kalafateli, Efthymios P. Tsounis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12864-12864
Open Access | Times Cited: 9
Updates in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Children
Kushila Rupasinghe, Jonathan Hind, Robert Hegarty
Journal of Pediatric Gastroenterology and Nutrition (2023) Vol. 77, Iss. 5, pp. 583-591
Closed Access | Times Cited: 9
Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography
Myung Jin Kim, Yun Kyung Cho, Eun Hee Kim, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 5, pp. 1942-1952
Open Access | Times Cited: 3
Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
Hongyan Wang, Yuxue Zhang, Yupeng Liu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity
Óscar Osorio-Conles, Arturo Vega‐Beyhart, Ainitze Ibarzábal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10541-10541
Open Access | Times Cited: 19
Metabolic dysfunction associated fatty liver disease in healthy weight individuals
Nahúm Méndez‐Sánchez, Willem Pieter Brouwer, Frank Lammert, et al.
Hepatology International (2024) Vol. 18, Iss. S2, pp. 884-896
Open Access | Times Cited: 2
Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver
Agostino Di Ciaula, Federico Carbone, Harshitha Shanmugham, et al.
European Journal of Internal Medicine (2021) Vol. 89, pp. 56-64
Open Access | Times Cited: 13
Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study
Francesco Baratta, Domenico Ferro, Daniele Pastori, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 17, pp. 8993-8993
Open Access | Times Cited: 13
Healthcare practitioners’ diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey
Marek Hartleb, Agnieszka Mastalerz–Migas, Piotr Kowalski, et al.
European Journal of Gastroenterology & Hepatology (2021) Vol. 34, Iss. 4, pp. 426-434
Open Access | Times Cited: 12
Mortality, Hepatic Decompensation, and Cardiovascular- and Renal-Related Outcomes in Lean Versus Non-lean Patients Hospitalized With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Chukwunonso Ezeani, Chidiebele Omaliko, Yazan A. Al‐Ajlouni, et al.
Cureus (2024)
Open Access | Times Cited: 1
Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth Comparison
Milena Vesković, M Pejović, Nikola Šutulović, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7405-7405
Open Access | Times Cited: 1
Lean metabolic dysfunction-associated steatotic disease is reversed by betulinic acid, a therapeutic triterpene from birch bark
Hyun Kyung Kim, Do‐Young Kim, Sumin Kang, et al.
Food Bioscience (2024), pp. 104376-104376
Closed Access | Times Cited: 1
Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or Obesity
Melissa Lopez‐Pentecost, Martha Taméz, Josiemer Mattei, et al.
Nutrients (2023) Vol. 15, Iss. 23, pp. 4997-4997
Open Access | Times Cited: 3
Lean Fatty Liver Disease: Through Thick and Thin
Madhumita Premkumar, Anil C. Anand
Journal of Clinical and Experimental Hepatology (2021) Vol. 11, Iss. 5, pp. 523-527
Open Access | Times Cited: 7
Liver Fibrosis Indices for the Prediction of Mortality in Korean Subjects: A 16-Year Prospective Cohort Study
Tae Jung Oh, Kyuho Kim, Jae Hoon Moon, et al.
Journal of the Endocrine Society (2021) Vol. 5, Iss. 10
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top